Covered recipient · General Payments record
SARA ANN LANCOUR
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2024
$314.73
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $314.73 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $62.65 | 3 |
| Ardelyx, Inc. | $54.14 | 3 |
| AIMMUNE THERAPEUTICS, INC. | $52.54 | 3 |
| ABBVIE INC. | $31.27 | 2 |
| ITI, Inc. | $30.74 | 1 |
| Lundbeck LLC | $30.11 | 2 |
| Lilly USA, LLC | $28.10 | 2 |
| ABIOMED | $25.18 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $314.73 | 17 |
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.48 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107504128 | CMS |
| ABBVIE INC. | $14.79 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107504130 | CMS |
| ABIOMED | $25.18 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142219778 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $19.02 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146976454 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $17.36 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146990563 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $16.16 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147004832 | CMS |
| Ardelyx, Inc. | $21.46 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146734032 | CMS |
| Ardelyx, Inc. | $18.48 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146734034 | CMS |
| Ardelyx, Inc. | $14.20 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146734036 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $30.74 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143530533 | CMS |
| Lilly USA, LLC | $14.79 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135943666 | CMS |
| Lilly USA, LLC | $13.31 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135959119 | CMS |
| Lundbeck LLC | $14.47 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146049262 | CMS |
| Lundbeck LLC | $15.64 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146049264 | CMS |
| Merck Sharp & Dohme LLC | $23.21 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141768063 | CMS |
| Merck Sharp & Dohme LLC | $17.92 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141890292 | CMS |
| Merck Sharp & Dohme LLC | $21.52 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141941985 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.